104 related articles for article (PubMed ID: 7743518)
1. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of chromosome 10p in human gliomas.
Kimmelman AC; Ross DA; Liang BC
Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
5. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site.
Reifenberger G; Reifenberger J; Ichimura K; Collins VP
Cancer Res; 1995 Feb; 55(4):731-4. PubMed ID: 7850781
[TBL] [Abstract][Full Text] [Related]
6. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval.
Rosenberg JE; Lisle DK; Burwick JA; Ueki K; von Deimling A; Mohrenweiser HW; Louis DN
Oncogene; 1996 Dec; 13(11):2483-5. PubMed ID: 8957092
[TBL] [Abstract][Full Text] [Related]
7. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
[TBL] [Abstract][Full Text] [Related]
8. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.
Rubio MP; Correa KM; Ueki K; Mohrenweiser HW; Gusella JF; von Deimling A; Louis DN
Cancer Res; 1994 Sep; 54(17):4760-3. PubMed ID: 8062276
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
Jin W; Xu X; Yang T; Hua Z
Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
[TBL] [Abstract][Full Text] [Related]
12. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
[TBL] [Abstract][Full Text] [Related]
13. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
Winqvist R; Mannermaa A; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee W
Cancer Res; 1993 Oct; 53(19):4486-8. PubMed ID: 8402619
[TBL] [Abstract][Full Text] [Related]
14. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
Negrini M; Rasio D; Hampton GM; Sabbioni S; Rattan S; Carter SL; Rosenberg AL; Schwartz GF; Shiloh Y; Cavenee WK
Cancer Res; 1995 Jul; 55(14):3003-7. PubMed ID: 7606718
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
Schofield DE; Beckwith JB; Sklar J
Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
[TBL] [Abstract][Full Text] [Related]
16. Deletion mapping of chromosome 10 in human glioma.
Sonoda Y; Murakami Y; Tominaga T; Kayama T; Yoshimoto T; Sekiya T
Jpn J Cancer Res; 1996 Apr; 87(4):363-7. PubMed ID: 8641967
[TBL] [Abstract][Full Text] [Related]
17. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
[TBL] [Abstract][Full Text] [Related]
19. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
Sasaki H; Betensky RA; Cairncross JG; Louis DN
Cancer Res; 2002 Mar; 62(6):1790-6. PubMed ID: 11912156
[TBL] [Abstract][Full Text] [Related]
20. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
